FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Category: Penny Stock News

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

Nordstrom Reports Dec. Sales (JWN)
Posted by samrogers on January 7th, 2013

http://pennyomega.com/img/crweresearch1.jpg

jwn Nordstrom, Inc. (NYSE: JWN)

Read More
comment 0
Share
Tags:

athenahealth (ATHN) to Acquire Mobile Health Leader Epocrates (EPOC)
Posted by trader888 on January 7th, 2013

bestotc_logo

signup3m

http://pennyomega.com/img/athn.pngATHN, athenahealth, Inc.

Read More
comment 0
Share
Tags:

eOn Communications (EONC) Reports FY2012 and Q1 FY2013 Profitability
Posted by drstockpick on January 7th, 2013

drstock-2-3

chartstockalert

http://pennyomega.com/img/eonc.jpg EONC, eOn Communications Corp.

Read More
comment 0
Share
Tags:

WNS (Holdings) Limited Enters into Strategic Partnership with Kinaxis (WNS)
Posted by austinmark on January 7th, 2013

crwefinancelogo2

chartstockalert

Read More
comment 0
Share
Tags:

Family Dollar Reports Q1 Results (FDO)
Posted by Steve Stock on January 7th, 2013

chartstockalert

 

Read More
comment 0
Share
Tags:

The Buckle Reports Dec. 2012 Net Sales (BKE)
Posted by stockrider on January 7th, 2013

signup3m

Read More
comment 0
Share
Tags:

Clermont County, OH Expands Partnership with Tyler Technologies (TYL)
Posted by PennyToBuck on January 7th, 2013

p-b2

chartstockalert

tyl Tyler Technologies, Inc. (NYSE: TYL)

Read More
comment 0
Share
Tags:

Celadon Trucking Services Reports the Acquisitions of Rock Leasing & Kelly Logistics (CGI)
Posted by CRWESelect Stoc... on January 7th, 2013

crweselectlogo-1

chartstockalert

Read More
comment 0
Share
Tags:

International Stem Cell Corp. (ISCO) Proclaims Liver Disease Program’s Success
Posted by QualityStocks on January 7th, 2013

International Stem Cell Corporation, a company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), today reported positive top line efficacy results from its pre-clinical in vivo liver study. The main goal of this study was to demonstrate the therapeutic equivalence of human parthenogenetic stem cell (hpSC)-derived hepatocytes to adult liver cells as a prerequisite for using such cells in the treatment of metabolic liver diseases, including Crigler-Najjar Syndrome (CNS).

Read More
comment 0
Share
Tags:

International Stem Cell Corp. (ISCO) Proclaims Liver Disease Program’s Success
Posted by QualityStocks on January 7th, 2013

International Stem Cell Corporation, a company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), today reported positive top line efficacy results from its pre-clinical in vivo liver study. The main goal of this study was to demonstrate the therapeutic equivalence of human parthenogenetic stem cell (hpSC)-derived hepatocytes to adult liver cells as a prerequisite for using such cells in the treatment of metabolic liver diseases, including Crigler-Najjar Syndrome (CNS).

Read More
comment 0
Share
Tags:

Pages

ADVERTISE WITH US